“…In 2022, Li and co-workers reported acridone-based derivatives named 2,7-DtBuCz-AD, 3,6-DtBuCzAD, 3,6-DMAC-AD, and 3,6-DMAC-AD-CF3, respectively. [26] The comparisons of decay curves for 2,7-DtBuCz-AD and 3,6-DtBuCzAD indicates that the introduction of donors on the C3 and C6 positions is beneficial for TADF properties. Small steric hindrance of carbazole and large ΔE ST (0.36 eV) contribute to the small k RISC of 0.3 × 10 3 s À 1 of 3,6-DtBuCzAD, 3,6-DMAC-AD, and 3,6-DMAC-AD-CF3 with 9,9-dimethyl-9,10-dihydroacridine (DMAC) as strong donors with large steric hindrance exhibit well-separated HOMO/LUMO distributions and distinct TADF properties (k RISC = 2.2/4.6 × 10 6 s À 1 ).…”